Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Vanguard Intermediate Term Corporate Bond ETF trades at $78.85 (market cap $72.20B). The key difference: Vanguard Intermediate Term Corporate Bond ETF is far larger — about 2.3× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| GEHC | VCIT | |
|---|---|---|
Market Cap | $30.93B | $72.20B |
Volume | 5,033,451 | 13,245,117 |
Sector | Health | Fixed Income |
52-Week High | $88.16 | $84.82 |
52-Week Low | $59.48 | $77.98 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 64 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
VCIT, the Vanguard Intermediate-Term Corporate Bond ETF, trades at $78.48, down 0.03% on the day. The technical outlook is mixed with a bullish overall signal but bearish moving averages, while fundamentals are supported by a 4.8% yield and low 0.03% expense ratio. Recent news highlights institutional buying and favorable comparisons to peer bond ETFs.
The outlook for VCIT is positive for income-focused investors seeking corporate bond exposure with low costs. Key opportunities include attractive yield and institutional interest, while risks involve interest rate sensitivity and credit spread volatility in the corporate bond market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
